Clinical Trial Update: Study Evaluating Cariprazine (RGH-188) in the Treatment of Patients With Acute Mania [Phase 2]

View source ↗

Summary

Phase 2 results for cariprazine (RGH-188) in acute mania associated with bipolar disorder have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• cariprazine (cariprazine)

Snippet

Sponsor: Forest Laboratories | Conditions: Bipolar Disorder | Phase 2 | Status: COMPLETED | Results posted: 2017-04-14